Globe Life (NYSE:GL) Stock Price Expected to Rise, JPMorgan Chase & Co. Analyst Says

Globe Life (NYSE:GL) had its target price raised by analysts at JPMorgan Chase & Co. from $181.00 to $201.00 in a report released on Tuesday,Benzinga reports. The firm currently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s price target suggests a potential upside of 9.41% from the company’s previous close.

Other equities research analysts have also issued research reports about the company. TD Cowen raised their target price on Globe Life from $199.00 to $215.00 and gave the stock a “buy” rating in a research report on Tuesday, June 23rd. Weiss Ratings raised Globe Life from a “buy (b-)” rating to a “buy (b)” rating in a report on Wednesday, May 13th. Truist Financial upped their price target on Globe Life from $180.00 to $185.00 and gave the company a “buy” rating in a report on Friday, April 24th. Jefferies Financial Group increased their price target on shares of Globe Life from $147.00 to $166.00 and gave the company a “hold” rating in a research note on Friday, July 10th. Finally, Piper Sandler boosted their price objective on shares of Globe Life from $175.00 to $200.00 and gave the stock an “overweight” rating in a research report on Wednesday, July 15th. One research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $187.60.

Globe Life Stock Performance

NYSE:GL opened at $183.71 on Tuesday. The firm has a market capitalization of $14.26 billion, a PE ratio of 12.70 and a beta of 0.47. The business’s fifty day moving average price is $168.37 and its 200 day moving average price is $152.54. The company has a debt-to-equity ratio of 0.38, a current ratio of 0.07 and a quick ratio of 0.07. Globe Life has a 12 month low of $122.48 and a 12 month high of $191.55.

Globe Life (NYSE:GL) last posted its quarterly earnings results on Wednesday, July 22nd. The company reported $3.61 earnings per share for the quarter, missing analysts’ consensus estimates of $3.67 by ($0.06). The business had revenue of $1.60 billion during the quarter, compared to analyst estimates of $1.59 billion. Globe Life had a net margin of 19.38% and a return on equity of 20.94%. The firm’s quarterly revenue was up 8.0% on a year-over-year basis. During the same quarter in the prior year, the business earned $3.05 earnings per share. Globe Life has set its FY 2026 guidance at 15.550-15.950 EPS. On average, sell-side analysts anticipate that Globe Life will post 15.64 earnings per share for the current fiscal year.

Insider Buying and Selling

In other news, CFO Thomas Peter Kalmbach sold 15,637 shares of the company’s stock in a transaction that occurred on Monday, May 11th. The stock was sold at an average price of $153.65, for a total transaction of $2,402,625.05. Following the completion of the sale, the chief financial officer owned 45,335 shares in the company, valued at $6,965,722.75. This represents a 25.65% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CEO James Matthew Darden sold 4,663 shares of the stock in a transaction on Tuesday, April 28th. The stock was sold at an average price of $153.88, for a total value of $717,542.44. Following the sale, the chief executive officer directly owned 58,451 shares of the company’s stock, valued at approximately $8,994,439.88. This represents a 7.39% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last ninety days, insiders sold 124,187 shares of company stock worth $19,529,414. 2.11% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Globe Life

A number of large investors have recently bought and sold shares of GL. Norges Bank acquired a new position in shares of Globe Life during the fourth quarter worth about $155,617,000. Northwestern Mutual Wealth Management Co. lifted its position in Globe Life by 34,786.0% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 881,919 shares of the company’s stock valued at $123,345,000 after purchasing an additional 879,391 shares during the period. AQR Capital Management LLC lifted its position in Globe Life by 98.6% in the second quarter. AQR Capital Management LLC now owns 1,402,690 shares of the company’s stock valued at $174,340,000 after purchasing an additional 696,548 shares during the period. Balyasny Asset Management L.P. purchased a new stake in Globe Life in the 3rd quarter valued at approximately $80,925,000. Finally, Arrowstreet Capital Limited Partnership boosted its holdings in Globe Life by 32.9% in the 4th quarter. Arrowstreet Capital Limited Partnership now owns 1,435,247 shares of the company’s stock valued at $200,734,000 after purchasing an additional 355,399 shares in the last quarter. Hedge funds and other institutional investors own 81.61% of the company’s stock.

Globe Life News Summary

Here are the key news stories impacting Globe Life this week:

• Positive Sentiment: Globe Life reported second-quarter net operating income of $3.61 per share, up from $3.27 a year ago, while net income came in at $3.65 per share, showing continued year-over-year earnings growth. GLOBE LIFE INC. REPORTS SECOND QUARTER 2026 RESULTS
• Positive Sentiment: Revenue of $1.60 billion slightly beat Wall Street expectations, suggesting the company is still growing its top line despite the earnings miss. View Press Release
• Positive Sentiment: TD Cowen raised its price target on Globe Life to $225 and kept a buy rating, while JPMorgan lifted its target to $201 with an overweight rating, signaling analyst confidence in the stock’s outlook. Benzinga
• Neutral Sentiment: Globe Life updated its FY 2026 EPS guidance to $15.55-$15.95, which brackets the consensus estimate of $15.65 and suggests management is generally reaffirming its full-year outlook. GLOBE LIFE INC. REPORTS SECOND QUARTER 2026 RESULTS
• Negative Sentiment: The quarter’s EPS of $3.61 missed the analyst consensus of $3.67 by $0.06, which may limit upside for the shares despite the stronger revenue performance. View Press Release

About Globe Life

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.